-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Meridian Bioscience Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2010 to 2022.
- Meridian Bioscience Inc Amortization of Intangible Assets for the quarter ending December 31, 2022 was $2.54M, a 2.34% increase year-over-year.
- Meridian Bioscience Inc Amortization of Intangible Assets for the twelve months ending December 31, 2022 was $9.97M, a 10.3% increase year-over-year.
- Meridian Bioscience Inc annual Amortization of Intangible Assets for 2022 was $9.91M, a 12.9% increase from 2021.
- Meridian Bioscience Inc annual Amortization of Intangible Assets for 2021 was $8.78M, a 13.3% increase from 2020.
- Meridian Bioscience Inc annual Amortization of Intangible Assets for 2020 was $7.74M, a 70.9% increase from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)